Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine
Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine's (JNM) July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 (18F) labeled ligand is a promising approach for diagnostic imaging. Current imaging modalities rely on structural characteristics, such as vascular flow impairment, and do not address the critical molecular components.
PET/CT imaging agent shows promise for better diagnosis of acute venous thromboembolism
PET/CT •
PHOTO GALLERY: What does COVID-19 look like on medical imaging?
FDA Grants Special Protocol Approval for Trial of Coronary Disease Radiotracer
Home Imaging Technology News
SNM Cardiovascular Symposium Focuses on Benefits of Imaging Modalities
Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes - ScienceDirect
18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
:max_bytes(150000):strip_icc()/brain-imaging-tests-5093826_final-46fa78279be7423e94e6923b6d43acd3.jpg)
Brain Imaging Tests
Nuclear Scanner Failures Detected With Real-Time Monitoring
Heart Hospital: A League of Their Own
DVTech - a novel wearable medical device to detect Deep Vein Thrombosis
How much does a PET scan cost?
Pharmaceuticals, Free Full-Text
